REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival. 2017

Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Republic of Korea.

Rab escort protein 1 (REP1) is a component of Rab geranyl-geranyl transferase 2 complex. Mutations in REP1 cause a disease called choroideremia (CHM), which is an X-linked eye disease. Although it is postulated that REP1 has functions in cell survival or death of various tissues in addition to the eye, how REP1 functions in normal and cancer cells remains to be elucidated. Here, we demonstrated that REP1 is required for the survival of intestinal cells in addition to eyes or a variety of cells in zebrafish, and also has important roles in tumorigenesis. Notably, REP1 is highly expressed in colon cancer tissues and cell lines, and silencing of REP1 sensitizes colon cancer cells to serum starvation- and 5-FU-induced apoptosis. In an effort to elucidate the molecular mechanisms underlying REP1-mediated cell survival under those stress conditions, we identified FOXO3 as a binding partner of REP1 using a yeast two-hybrid (Y2H) assay system, and we demonstrated that REP1 blocked the nuclear trans-localization of FOXO3 through physically interacting with FOXO3, thereby suppressing FOXO3-mediated apoptosis. Importantly, the inhibition of REP1 combined with 5-FU treatment could lead to significant retarded tumor growth in a xenograft tumor model of human cancer cells. Thus, our results suggest that REP1 could be a new therapeutic target in combination treatment for colon cancer patients.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071316 Forkhead Box Protein O3 A forkhead box transcription factor and transcriptional activator which triggers type 1 programmed cell death (APOPTOSIS) in the absence of APOPTOSIS INHIBITING PROTEINS, including neuronal cell death induced by OXIDATIVE STRESS. It recognizes and binds to the DNA sequence 5'-(AG)TAAA(TC)A-3' and also functions in post-transcriptional regulation of the c-MYC PROTO-ONCOGENE. FOXO3 Protein,Forkhead in Rhabdomyosarcoma-Like 1 Protein,Forkhead in Rhabdomyosarcoma Like 1 Protein,Protein, FOXO3
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015027 Zebrafish An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research. Brachydanio rerio,Danio rerio,B. rerio,D. rerio,Zebra Fish,Zebra Fishes,Zebra danio,Zebrafishes,D. rerios,Fishes, Zebra,Zebra danios,danio, Zebra
D015794 Choroideremia An X chromosome-linked abnormality characterized by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness. Progressive Tapetochoroidal Dystrophy,Tapetochoroidal Dystrophy, Progressive,Choroideremias,Dystrophies, Progressive Tapetochoroidal,Dystrophy, Progressive Tapetochoroidal,Progressive Tapetochoroidal Dystrophies,Tapetochoroidal Dystrophies, Progressive

Related Publications

Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
January 2020, Experimental and therapeutic medicine,
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
August 2017, International journal of molecular sciences,
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
March 2024, Advanced science (Weinheim, Baden-Wurttemberg, Germany),
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
March 2015, Apoptosis : an international journal on programmed cell death,
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
June 2017, The Journal of clinical investigation,
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
June 2024, Apoptosis : an international journal on programmed cell death,
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
June 2018, Cancer research,
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
December 2023, Biochemical pharmacology,
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
September 2015, Protein & cell,
Kwon-Ho Song, and Seon Rang Woo, and Joon-Yong Chung, and Hyo-Jung Lee, and Se Jin Oh, and Soon-Oh Hong, and Jaegal Shim, and Yong Nyun Kim, and Seung Bae Rho, and Seung-Mo Hong, and Hanbyoul Cho, and Masahiko Hibi, and Dong-Jun Bae, and Sang-Yeob Kim, and Min Gyu Kim, and Tae Woo Kim, and Young-Ki Bae
July 2023, Journal of cellular and molecular medicine,
Copied contents to your clipboard!